The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma: a multicenter retrospective study

被引:42
作者
Ding, Xiaojie [1 ]
Wang, Zheng [2 ]
Chen, Di [1 ]
Wang, Yinyan [3 ]
Zhao, Zheng [2 ]
Sun, Chongran [4 ]
Chen, Dikang [1 ]
Tang, Chao [1 ,5 ]
Xiong, Ji [6 ]
Chen, Lingchao [1 ,5 ]
Yao, Zhenwei [7 ]
Liu, Ying [8 ]
Wang, Xiaoqin [9 ]
Cahill, Daniel P. [10 ]
de Groot, John F. [11 ]
Jiang, Tao [2 ,3 ]
Yao, Yu [1 ,5 ]
Zhou, Liangfu [1 ,5 ]
机构
[1] Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Mid Wulumuqi Rd, Shanghai, Peoples R China
[2] Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, 6 Tiantanxili, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, 6 Tiantanxili, Beijing, Peoples R China
[4] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China
[5] Fudan Univ, Neurosurg Inst, Neurosurg Immunol Lab, Shanghai, Peoples R China
[6] Fudan Univ, Huashan Hosp, Dept Pathol, Shanghai, Peoples R China
[7] Fudan Univ, Huashan Hosp, Dept Radiol, Shanghai, Peoples R China
[8] Fudan Univ, Dept Pathol, Basic Med Sci, Shanghai, Peoples R China
[9] Fudan Univ, Evidence Based Med Ctr, Shanghai, Peoples R China
[10] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA USA
[11] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA
关键词
Glioma; Extent of resection; Prognostic value; Molecular subgroup; TERT PROMOTER MUTATIONS; CENTRAL-NERVOUS-SYSTEM; GRADE; CHEMOTHERAPY; SURVIVAL; 1P/19Q; EXTENT; IDH;
D O I
10.1007/s11060-018-2985-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Maximal surgical resection is associated with survival benefit in the majority of studies in adult diffuse glioma. This study aims to characterize the prognostic value of surgical resection in molecular subgroups of diffuse glioma. Methods 1178 patients with diffuse glioma from our centers and 422 from TCGA dataset were collected. The Kaplan-Meier analysis and multivariable Cox regression models were conducted to identify the prognostic value of surgical resection through different histological and molecular stratifications. Results Firstly, we confirmed progression-free survival (PFS) benefit associated with gross total resection (GTR) over sub-total resection (STR) in lower-grade glioma (HR 1.49; 95% CI 1.17-1.90; P = 0.001). Intriguingly however, we were unable to detect a significant PFS or overall survival (OS) benefit in oligodendroglioma (N = 397; HR 1.36; 95% CI 0.86-2.14; P = 0.19 and HR 1.05; 95% CI 0.55-1.99; P = 0.89, respectively). Secondly, when analyzed in molecular subgroups, we were similarly unable to detect a significant PFS or OS benefit in IDH MT/codel subgroup (N = 269; HR 1.47; 95% CI 0.92-2.34; P = 0.11 and HR 1.54; 95% CI 0.78-3.05; P = 0.21, respectively), oligodendroglioma with IDH MT/codel subgroup (N=233; HR 1.33; 95% CI 0.79-2.21; P = 0.28 and HR 1.16; 95% CI 0.53-2.54; P = 0.70, respectively) or other relevant subgroups. TCGA validation also showed a significant survival benefit in astrocytoma rather than oligodendroglioma. Exploratory RNAseq analysis displayed that fewer cell proliferation-related gene expression features were specific to oligodendroglioma. Conclusion These results suggest that the benefit of maximal surgery may be attenuated in patients within oligodendroglioma relevant subgroups because of the chemosensitive and indolent nature. The aggressive surgery accompanying with risk of neurologic morbidity may be unnecessary for these patients given the lack of survival benefit with gross total resection.
引用
收藏
页码:591 / 603
页数:13
相关论文
共 26 条
  • [1] Microfluidics for rapid detection of isocitrate dehydrogenase 1 mutation for intraoperative application
    Aibaidula, Abudumijiti
    Zhao, Wang
    Wu, Jin-song
    Chen, Hong
    Shi, Zhi-feng
    Zheng, Lu-lu
    Mao, Ying
    Zhou, Liang-fu
    Sui, Guo-dong
    [J]. JOURNAL OF NEUROSURGERY, 2016, 124 (06) : 1611 - 1618
  • [2] Effects of medulloblastoma resections on outcome in children: A report from the children's cancer group
    Albright, AL
    Wisoff, JH
    Zeltzer, PM
    Boyett, JM
    Rorke, LB
    Stanley, P
    [J]. NEUROSURGERY, 1996, 38 (02) : 265 - 270
  • [3] RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas
    Bao, Zhao-Shi
    Chen, Hui-Min
    Yang, Ming-Yu
    Zhang, Chuan-Bao
    Yu, Kai
    Ye, Wan-Lu
    Hu, Bo-Qiang
    Yan, Wei
    Zhang, Wei
    Akers, Johnny
    Ramakrishnan, Valya
    Li, Jie
    Carter, Bob
    Liu, Yan-Wei
    Hu, Hui-Min
    Wang, Zheng
    Li, Ming-Yang
    Yao, Kun
    Qiu, Xiao-Guang
    Kang, Chun-Sheng
    You, Yong-Ping
    Fan, Xiao-Long
    Song, Wei Sonya
    Li, Rui-Qiang
    Su, Xiao-Dong
    Chen, Clark C.
    Jiang, Tao
    [J]. GENOME RESEARCH, 2014, 24 (11) : 1765 - 1773
  • [4] IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection
    Beiko, Jason
    Suki, Dima
    Hess, Kenneth R.
    Fox, Benjamin D.
    Cheung, Vincent
    Cabral, Matthew
    Shonka, Nicole
    Gilbert, Mark R.
    Sawaya, Raymond
    Prabhu, Sujit S.
    Weinberg, Jeffrey
    Lang, Frederick F.
    Aldape, Kenneth D.
    Sulman, Erik P.
    Rao, Ganesh
    McCutcheon, Ian E.
    Cahill, Daniel P.
    [J]. NEURO-ONCOLOGY, 2014, 16 (01) : 81 - 91
  • [5] Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
    Brat, Daniel J.
    Verhaak, Roel G. W.
    Al-dape, Kenneth D.
    Yung, W. K. Alfred
    Salama, Sofie R.
    Cooper, Lee A. D.
    Rheinbay, Esther
    Miller, C. Ryan
    Vitucci, Mark
    Morozova, Olena
    Robertson, A. Gordon
    Noushmehr, Houtan
    Laird, Peter W.
    Cherniack, Andrew D.
    Akbani, Rehan
    Huse, Jason T.
    Ciriello, Giovanni
    Poisson, Laila M.
    Barnholtz-Sloan, Jill S.
    Berger, Mitchel S.
    Brennan, Cameron
    Colen, Rivka R.
    Colman, Howard
    Flanders, Adam E.
    Giannini, Caterina
    Grifford, Mia
    Iavarone, Antonio
    Jain, Rajan
    Joseph, Isaac
    Kim, Jaegil
    Kasaian, Katayoon
    Mikkelsen, Tom
    Murray, Bradley A.
    O'Neill, Brian Patrick
    Pachter, Lior
    Parsons, Donald W.
    Sougnez, Carrie
    Sulman, Erik P.
    Vandenberg, Scott R.
    Van Meir, Erwin G.
    von Deimling, Andreas
    Zhang, Hailei
    Crain, Daniel
    Lau, Kevin
    Mallery, David
    Morris, Scott
    Paulauskis, Joseph
    Penny, Robert
    Shelton, Troy
    Sherman, Mark
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (26) : 2481 - 2498
  • [6] The Somatic Genomic Landscape of Glioblastoma
    Brennan, Cameron W.
    Verhaak, Roel G. W.
    McKenna, Aaron
    Campos, Benito
    Noushmehr, Houtan
    Salama, Sofie R.
    Zheng, Siyuan
    Chakravarty, Debyani
    Sanborn, J. Zachary
    Berman, Samuel H.
    Beroukhim, Rameen
    Bernard, Brady
    Wu, Chang-Jiun
    Genovese, Giannicola
    Shmulevich, Ilya
    Barnholtz-Sloan, Jill
    Zou, Lihua
    Vegesna, Rahulsimham
    Shukla, Sachet A.
    Ciriello, Giovanni
    Yung, W. K.
    Zhang, Wei
    Sougnez, Carrie
    Mikkelsen, Tom
    Aldape, Kenneth
    Bigner, Darell D.
    Van Meir, Erwin G.
    Prados, Michael
    Sloan, Andrew
    Black, Keith L.
    Eschbacher, Jennifer
    Finocchiaro, Gaetano
    Friedman, William
    Andrews, David W.
    Guha, Abhijit
    Iacocca, Mary
    O'Neill, Brian P.
    Foltz, Greg
    Myers, Jerome
    Weisenberger, Daniel J.
    Penny, Robert
    Kucherlapati, Raju
    Perou, Charles M.
    Hayes, D. Neil
    Gibbs, Richard
    Marra, Marco
    Mills, Gordon B.
    Lander, Eric
    Spellman, Paul
    Wilson, Richard
    [J]. CELL, 2013, 155 (02) : 462 - 477
  • [7] Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
    Cairncross, Gregory
    Wang, Meihua
    Shaw, Edward
    Jenkins, Robert
    Brachman, David
    Buckner, Jan
    Fink, Karen
    Souhami, Luis
    Laperriere, Normand
    Curran, Walter
    Mehta, Minesh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (03) : 337 - 343
  • [8] TERT promoter mutations contribute to subset prognostication of lower-grade gliomas
    Chan, Aden Ka-Yin
    Yao, Yu
    Zhang, Zhenyu
    Chung, Nellie Yuk-Fei
    Liu, Joseph Shu-Ming
    Li, Kay Ka-Wai
    Shi, Zhifeng
    Chan, Danny Tat-Ming
    Poon, Wai Sang
    Zhou, Liangfu
    Ng, Ho-Keung
    [J]. MODERN PATHOLOGY, 2015, 28 (02) : 177 - 186
  • [9] Case 38-2016: A 52-Year-Old Woman with Recurrent Oligodendroglioma
    Chi, Andrew S.
    Cahill, Daniel P.
    Larvie, Mykol
    Louis, David N.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (24) : 2381 - 2389
  • [10] Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group study 93-10
    DeAngelis, LM
    Seiferheld, W
    Schold, SC
    Fisher, B
    Schultz, CJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (24) : 4643 - 4648